About AHG

Founded: 2014
Employees: 27
CEO: Yilin Wang
WebsiteView website: www.ahgtop.com

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Recent AHG News & Updates

Announcement • Apr 29

Akso Health Group Announces Initiation of Proprietary Brain-Computer Interface Technology Research and Development Program

Akso Health Group announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development program. The Company is establishing the foundational R&D infrastructure necessary to develop and commercialize BCI technology, which it believes represents one of the most transformative and high-value technology frontiers of the 21st century. AHG is developing proprietary innovations in ultra-high-resolution neural sensing, real-time AI neural decoding, and next-generation interface design, with patent applications pending. The Company intends to engineer its BCI program to address unmet needs across neuroscience, advanced therapeutics, and human-machine interaction, subject to successful research, development, and regulatory processes. The Company has not commenced any human clinical trials, has not made any regulatory submissions to the FDA or any other regulatory authority, and is not generating any revenue from BCI-related activities. There can be no assurance that any product candidate will be successfully developed, approved by regulators, or commercialized. Investors should not place undue reliance on forward-looking statements in this release.

Recent updates

No updates

Akso Health Group Stock Price

AHG Share Price Performance

AHG Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Akso Health Group Key Details

About AHG

Recent AHG News & Updates

Akso Health Group (AHG) Stock Looks Expensive Despite Stronger Quarterly Revenue

Akso Health Group Announces Initiation of Proprietary Brain-Computer Interface Technology Research and Development Program

First half 2026 earnings released: US$0.002 loss per share (vs US$0.003 loss in 1H 2025)

Recent updates

Akso Health Group Competitors

Lantheus Holdings

Hinge Health

PACS Group

Chemed